14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.872 2 days ( 2.36 % )
Last Price $0.700 -2.36 %
High/ Low $0.700 - $0.740 11.41%
Chg 7 Days -0.667 % $0.705 $0.700
Chg 30 Days -4.40 % $0.732 $0.700
Chg 12 mos -67.29 % $2.14 $0.700
Trend - 3 mos 2.55 % Width: 34.92 %
Trend - 12 mos -78.19 % Width: 214.63 %
Pred. range - 3 mos $0.688 - $0.93 -1.70 % - 32.63 %
Pred. range - 12 mos N/A - $0.123 -100.00 % - -82.50 %
Short MA avg 3 mos Buy May 01, 2024 - 3 days
Long MA avg 3 mos Buy Apr 04, 2024 - 22 days
Short/Long MA avg 3 mos Sell Apr 03, 2024 - 23 days
Short MA avg 12 mos Buy May 01, 2024 - 3 days
Long MA avg 12 mos Buy May 01, 2024 - 3 days
Short/Long MA avg 12 mos Sell Apr 30, 2024 - 4 days
Pivot Short Sell Apr 25, 2024 - 7 days
Bollinger Buy Apr 12, 2024 - 16 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Galecto, Inc.

Galecto. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a ... GLTO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT